Indeed, in vitro, CD4+ CAR T cells were shown to exert cytotoxic activity against tumor cells, although at a lower level than CD8+ CAR T cells, but to produce more IFN-γ and TNF, and to proliferate more extensively upon contact with tumor cells [108]. The gene discussed is CD8A; the disease is neoplasm.